Arterial Resection in Pancreatic Cancer: Weighing Feasibility, Morbidity, and Necessity in High-Volume Centers

In the quest for curative pancreatectomy for pancreatic cancer, researchers delve into arterial resection’s (AR) feasibility and outcomes. Analyzing 259 patients, they find AR, despite longer operation times, rivals venous resection in morbidity. Surprisingly, arterial infiltration’s likelihood is questioned, suggesting AR might be replaceable by less invasive techniques. This study at a high-volume pancreatic surgery center challenges the controversy surrounding AR, emphasizing its potential viability with comparable outcomes to venous resection.